Debunking The Lie: “Cancer Pain and Non-Cancer Pain Should Be Treated Differently”

FACT: There is no scientific, physiological, or pharmacological difference in how opioids treat cancer versus non-cancer pain. The body’s pain pathways and opioid receptors work the same in both cases.

The cancer vs. non-cancer divide was manufactured, not discovered. It began with early policy documents like Washington State’s AMDG guideline and was cemented when PROP (Physicians for Responsible Opioid Prescribing) petitioned the FDA in 2012 to restrict opioids for all pain except cancer.

After reviewing the evidence, the FDA rejected this framing, stating there was “no physiological or pharmacological basis” to treat cancer and non-cancer pain differently. Yet the false distinction spread through the CDC’s 2016 guideline, state laws, insurance rules, and even prosecutions, because it served political and litigation goals.

Leading pain experts such as Schatman and Peppin have called it a “distinction without a difference,” emphasizing that opioids work the same way regardless of diagnosis.

Today, even cancer patients face pharmacy denials, PDMP flags, and stigma once reserved for “non-cancer” pain patients. This false divide has harmed everyone by replacing compassion and science with fear and control.

Pain is pain. No credible study has ever shown otherwise. It’s time to remove this unscientific distinction from all laws, guidelines, and policies, and let clinicians treat the patient in front of them.

Read the full breakdown, citations, and printable resources on our Patreon page.